CanFite BioPharma

About:

Can-Fite BioPharma is a bio-pharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities.

Website: http://www.canfite.com

Top Investors: Yozma Group, Giza Venture Capital, Cybele Holdings, SCP Vitalife Partners, Ascend Technology Ventures

Description:

Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases.

Total Funding Amount:

$88.4M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Petah Tiqva, HaMerkaz, Israel

Founded Date:

1994-01-01

Contact Email:

info(AT)canfite.co.il

Founders:

Pnina Fishman

Number of Employees:

1-10

Last Funding Date:

2024-08-08

IPO Status:

Public

Industries:

© 2025 bioDAO.ai